Prescribing controlled substances via telehealth
Authorized providers are able to prescribe controlled substances via telehealth if they meet certain criteria.
The Drug Enforcement Administration (DEA), jointly with the Department of Health and Human Services (HHS), has extended the full set of telemedicine flexibilities regarding the prescribing of controlled medications as were in place during the COVID-19 public health emergency (PHE), through December 31, 2025.
Telemedicine flexibilities regarding prescription of controlled medications include:
- A DEA-registered practitioner can prescribe a schedule II-V controlled substance to a patient using telemedicine without having conducted an in-person medical evaluation if required conditions are met.
For more information, see: